Nature Medicine - Current issue : July 2009, Volume 15 No 7
- Lymphotoxin-alpha targets troublesome T cells
- A small molecule against Ewing's sarcoma
- Inhibiting cancer pain
Latest highlights
News Feature
Outpacing cancer
Feature by Kirsten DoransDespite the arrival of gefitinib, non-small cell lung cancer continues to be a moving target. How are scientists approaching this continually evolving form of cancer?
Meeting
Frontiers of clinical investigation—Metabolism
Metabolism 2009: From bench to bedsideWe invite you to attend the 4th Annual Frontiers of Clinical Investigation Symposium. The meeting will explore innovative approaches to bridge laboratory investigation and clinical research in metabolism.
News & Views
Hedgehog inhibitor pokes tumor
Community CornerPatients with ductal adenocarcinoma, a common form of pancreatic cancer, barely respond to therapy, but a study in mice opens the door to a new approach. What do the experts say?
News & Views
Damage control in the nervous system
Between Bedside and BenchThis month, Fawcett and Curt examine how rehabilitation therapy can affect brain plasticity, while Popovich and McTigue highlight the role of the immune system on spinal cord injury.
Current Issue
Receptors for hand, foot and mouth virus found
Letter by Nishimura et al. Letter by Yamayoshi et al.Two receptors have now been identified for the virus behind severe hand, foot and mouth disease.
See also:
News and Views by Patel & BergelsonNew!
SciBX: Ask your librarian to start a trial today!
SciBX: Science-Business eXchange is a weekly publication that identifies and analyses the most important translational research articles from over 40 journals. Find out which papers have real scientific and commercial potential, and why. Subscribe to SciBX and you won't miss the next big thing.
SciBX is now available in full-text, HTML format on the nature.com platform.
Recommend SciBX to your library today
For more information visit: www.nature.com/scibx/
